Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17,331 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric cancer.
Li S, Yu W, Xie F, Luo H, Liu Z, Lv W, Shi D, Yu D, Gao P, Chen C, Wei M, Zhou W, Wang J, Zhao Z, Dai X, Xu Q, Zhang X, Huang M, Huang K, Wang J, Li J, Sheng L, Liu L. Li S, et al. Among authors: huang k, huang m. Nat Commun. 2023 Jan 3;14(1):8. doi: 10.1038/s41467-022-35431-x. Nat Commun. 2023. PMID: 36596787 Free PMC article. Clinical Trial.
Selection of optimal first-line immuno-related therapy based on specific pathological characteristics for patients with advanced driver-gene wild-type non-small cell lung cancer: a systematic review and network meta-analysis.
Sheng L, Gao J, Xu Q, Zhang X, Huang M, Dai X, Li S, Liu L. Sheng L, et al. Among authors: huang m. Ther Adv Med Oncol. 2021 May 29;13:17588359211018537. doi: 10.1177/17588359211018537. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 34104227 Free PMC article. Review.
Exosomes Promote Pre-Metastatic Niche Formation in Gastric Cancer.
Gao J, Li S, Xu Q, Zhang X, Huang M, Dai X, Liu L. Gao J, et al. Among authors: huang m. Front Oncol. 2021 May 24;11:652378. doi: 10.3389/fonc.2021.652378. eCollection 2021. Front Oncol. 2021. PMID: 34109113 Free PMC article. Review.
Comparison of Efficacy and Safety of Single and Double Immune Checkpoint Inhibitor-Based First-Line Treatments for Advanced Driver-Gene Wild-Type Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis.
Xu Q, Zhang X, Huang M, Dai X, Gao J, Li S, Sheng L, Huang K, Wang J, Liu L. Xu Q, et al. Among authors: huang k, huang m. Front Immunol. 2021 Aug 16;12:731546. doi: 10.3389/fimmu.2021.731546. eCollection 2021. Front Immunol. 2021. PMID: 34484242 Free PMC article.
What Is Long-Term Survival and Which First-Line Immunotherapy Brings Long-Term Survival for Advanced Wild-Type Non-Small Cell Lung Cancer: A Network Meta-Analysis Based on Integrated Analysis.
Zhang X, Xu Q, Yu X, Huang M, Li S, Sheng L, Dai X, Huang K, Wang J, Liu L. Zhang X, et al. Among authors: huang k, huang m. Front Immunol. 2022 Apr 5;13:764643. doi: 10.3389/fimmu.2022.764643. eCollection 2022. Front Immunol. 2022. PMID: 35450068 Free PMC article.
Pyroptosis predicts immunotherapy outcomes across multiple cancer types.
Li S, Chen P, Cheng B, Liu Y, Zhang X, Xu Q, Huang M, Dai X, Huang K, Zhang L, Cheng Y, Liu L. Li S, et al. Among authors: huang k, huang m. Clin Immunol. 2022 Dec;245:109163. doi: 10.1016/j.clim.2022.109163. Epub 2022 Oct 13. Clin Immunol. 2022. PMID: 36244669
[No title available]
[No authors listed] [No authors listed] PMID: 36941478
17,331 results
You have reached the last available page of results. Please see the User Guide for more information.